ESR1 and triple-negative breast carcinoma: To investigate if estrogen receptor expression could affect our identified AS changes, we validate the selected 20 events in additional breast cancer cell lines ER-positive (T47D) and triple-negative breast cancer cells (TNBC) (MDA-MB-231 and BT549) [41].